Recent insider trading activity from Nazak Michael Adrian, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2023 | AN2 Therapeutics, Inc. | $ANTX | Nazak Michael Adrian | Chief Accounting Officer | A | Stock Option (right to buy) | 16600 | $0.00 | 16,600.0000 | 0 | 9999.99% | 0.00% |